CNMD Stock Summary and Trading Ideas (Conmed | NYSE:CNMD)

Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.

Conmed trades on the NYSE stock market under the symbol CNMD.

As of September 15, 2026, CNMD stock price climbed to $46.95 with 398,876 million shares trading.

CNMD has a beta of 1.00, meaning it tends to be more sensitive to market movements. CNMD has a correlation of 0.08 to the broad based SPY ETF.

CNMD has a market cap of $1.41 billion. This is considered a Small Cap stock.

Last quarter Conmed reported $343 million in Revenue and $1.38 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.27.

In the last 3 years, CNMD traded as high as $117.27 and as low as $31.44.

The top ETF exchange traded funds that CNMD belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.

CNMD has underperformed the market in the last year with a price return of -10.5% while the SPY ETF gained +16.4%. However, in the short term, CNMD had mixed performance relative to the market. It has outperformed in the last 3 months, returning +35.0% vs +2.4% return in SPY. But in the last 2 weeks, CNMD shares have been beat by the market, returning -5.8% compared to an SPY return of -1.3%.

CNMD support price is $45.24 and resistance is $47.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNMD shares will trade within this expected range on the day.